Carnegie Mellon University   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Pittsburgh PA United States (1900)

Organization Overview

First Clinical Trial
2017
NCT02606045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Barry Dewitt | Carnegie Mellon University